You are viewing: North America Empty Capsules Market analysis
Part of: Empty Capsules Market (Global)

The North America Empty Capsules Market was valued at $1101.4 Million in 2025 and projected to reach to $1454.3 Million by 2030, representing a compound annual growth rate of 5.7%. The North America empty capsules market is positioned for steady expansion through 2030, driven by the region's leadership in pharmaceutical innovation and the growing nutraceutical sector.

North America Empty Capsules Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Empty Capsules Market Trends and Insights

  • North America's dominance in pharmaceutical manufacturing and nutraceutical production drives sustained demand for empty capsules across the region.
  • The market in North America benefits from advanced healthcare infrastructure, stringent quality standards, and a robust pharmaceutical supply chain that supports both generic and branded drug manufacturers. Growth in North America is fueled by increasing consumer demand for dietary supplements, rising pharmaceutical outsourcing, and the expansion of contract manufacturing organizations (CMOs) throughout the region.
  • North America's regulatory environment, including FDA oversight, ensures high-quality capsule production and encourages investment in capsule manufacturing facilities.
  • Between 2025 and 2030, North America is expected to maintain its position as a key market for empty capsules, driven by innovation in capsule materials, growing preference for plant-based alternatives, and the region's commitment to pharmaceutical excellence..

Key Market Statistics

  • CAGR (2025-2030) 5.7% CAGR
  • Market Size, 2025 ~USD 1101.4 Million
  • Forecast, 2030 ~USD 1454.3 Million
  • Geography North America

North America Empty Capsules Market Overview

US Market Dominance :

The United States accounts for $822.1 million of North America's empty capsules market, representing approximately 75% of the region's total value and driving significant growth through robust pharmaceutical and nutraceutical manufacturing sectors.

Sustained 5.7% Regional CAGR :

North America's empty capsules market is projected to grow at 5.7% CAGR from 2025 to 2030, outpacing the global growth rate of 5.6%, reflecting strong regional demand and advanced healthcare infrastructure.

Advanced Manufacturing Infrastructure :

North America benefits from state-of-the-art pharmaceutical manufacturing facilities, stringent quality standards, and established supply chains that support consistent demand for high-quality empty capsules across multiple applications.

Nutraceutical Sector Growth :

The region's thriving dietary supplement and nutraceutical industry continues to drive significant consumption of empty capsules, supported by consumer wellness trends and increasing health-conscious purchasing behavior.

North America Empty Capsules Market Dynamics

  • The US market's substantial contribution of $822.1 million provides a strong foundation for regional growth, while Canada's emerging market at $73.2 million presents additional opportunities.
  • Regulatory compliance, advanced manufacturing capabilities, and established distribution networks continue to support market stability and expansion across the region. Key growth drivers include increasing demand for customized capsule solutions, expansion of contract manufacturing organizations, and rising consumer preference for capsule-based supplements.
  • The region's commitment to pharmaceutical excellence and quality assurance positions North America as a premium market segment, supporting higher-value capsule products and specialized formulations that command premium pricing..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • North America's empty capsules market is valued at $1,101.4 million in 2025 and will reach $1,454.3 million by 2030 at a 5.7% CAGR.
    • North America's advanced pharmaceutical infrastructure and FDA regulations support consistent demand for high-quality empty capsules.
    • Growing consumer preference for dietary supplements and nutraceuticals in North America drives market expansion through 2030.
    • North America's contract manufacturing sector and pharmaceutical outsourcing trends accelerate adoption of empty capsules across the region.

    Empty Capsules Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SUSTAINED-RELEASE CAPSULES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.6% from 2025 to 2030
    Largest Segment IMMEDIATE-RELEASE CAPSULES (Functionality)
    Market Size Base Year (Billions) ~USD 3.19 (2025)
    Revenue Forecast (Billions) ~USD 4.19 (2030)
    Segments Covered Type, Raw Material, Functionality, Size, Therapeutic Application, End User

    North America Empty Capsules Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • Gelatin Capsules
    • Non-Gelatin Capsules

    By Raw Material

    • Bonemeal Gelatin
    • Bovine-Derived Gelatin
    • Hydroxypropyl Methylcellulose (Hpmc)
    • Other Gelatin Sources
    • Porcine Gelatin
    • Pullulan & Starch

    By Functionality

    • Delayed-Release Capsules
    • Immediate-Release Capsules
    • Sustained-Release Capsules

    By Size

    • Size 0
    • Size 00
    • Size 000
    • Size 1
    • Size 2
    • Size 3
    • Size 4
    • Size 5

    By Therapeutic Application

    • Antacid & Antiflatulent Preparations
    • Anti-Inflammatory Drugs
    • Antianemic Preparations
    • Antibiotic & Antibacterial Drugs
    • Cardiovascular Therapy Drugs
    • Cough & Cold Drugs
    • Dietary Supplements
    • Other Therapeutic Applications

    By End User

    • Cosmetic Industry
    • Nutraceutical Industry
    • Pharmaceutical Industry
    • Research Laboratories

    Target Audience

    • Pharmaceutical Manufacturers : North America-based and international pharmaceutical companies require detailed market data to optimize capsule sourcing, plan production capacity, and identify contract manufacturing opportunities across the US and Canadian markets.
    • Nutraceutical & Supplement Producers : Dietary supplement and wellness product manufacturers need region-specific insights into capsule demand trends, consumer preferences, and supply chain dynamics to support their growing product portfolios in North America.
    • Capsule Manufacturers & Suppliers : Empty capsule producers and raw material suppliers require detailed North America market analysis to identify growth opportunities, assess competitive positioning, and develop region-specific product and pricing strategies.
    • Contract Manufacturing Organizations (CMOs) : CMOs operating in North America need market intelligence to understand capsule demand patterns, client requirements, and growth opportunities within the region's pharmaceutical and nutraceutical outsourcing sectors.
    • Investment & Business Development Teams : Private equity firms, venture capital investors, and business development professionals require North America market data to evaluate investment opportunities, assess market attractiveness, and support M&A activities in the capsules sector.

    Key Companies in the North America Empty Capsules Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, clinical trial supply),Drug substance services (API and biologics substance),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics and dermatology,Eye care,Neuroscience and CNS,
    HELM AGGermanyPrivate CompanyBasic Chemicals, Acids and Lyes,Plastics and Polyurethanes,Crop Protection and Fertilizers,
    SUNIL HEALTHCARE LIMITEDIndiaPublic CompanyStandard empty hard gelatin capsules (incl. BSE/TSE free, pearl, natural color),Functional and specialty capsules (liquid-fill, preservative-free, stick-free, flavored, SLS-free, non-AZO),HPMC/vegetable capsules,
    NATURAL CAPSULES LIMITEDIndiaPublic CompanyStandard hard gelatin capsule shells,Vegetarian and cellulose-based capsule shells,Enteric, fast-release, and functional capsules,
    ANHUI HUANGSHAN CAPSULE CO., LTD.ChinaPublic CompanyVacant gelatin capsules (standard),Enteric-coated / entersoluble gelatin capsules,Vegetable capsules (HPMC, pullulan, vegetable entersoluble),

    PATHEON INC

    Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and contract manufacturing sector.

    ALLERGAN PLC

    Allergan PLC is an Ireland-incorporated private company founded in 1983 with 17,400 employees, operating in the pharmaceutical and specialty healthcare industry.

    HELM AG

    Helm AG is a Germany-based private company founded in 1900 with 1,430 employees, operating in the pharmaceutical and chemical distribution industry.

    SUNIL HEALTHCARE LIMITED

    Sunil Healthcare Limited is an India-based public company founded in 1973 with 161 employees operating in the pharmaceutical sector.

    NATURAL CAPSULES LIMITED

    Natural Capsules Limited is an India-based public company founded in 1993 with 615 employees operating in the pharmaceutical capsule manufacturing industry.

    ANHUI HUANGSHAN CAPSULE CO., LTD.

    Anhui Huangshan Capsule Co., Ltd. is a China-based public company founded in 1989 with 639 employees operating in the pharmaceutical capsule manufacturing industry.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 1233.2 Million · 5.5% wtd CAGR ·
    Asia Pacific
    ~USD 1198.2 Million · 6% wtd CAGR ·
    Latin America
    ~USD 210.4 Million · 5% wtd CAGR ·
    Middle East
    ~USD 68.5 Million · 3.6% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 822.1 Million
    CanadaUSD 73.2 Million

    Country market size visualization

    US
    USD 822.1 Million
    Canada
    USD 73.2 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into North America's empty capsules market with country-level breakdown including the US ($822.1M) and Canada ($73.2M), enabling precise market targeting and localized business strategy development.
    • Growth Trajectory Analysis : Understand the 5.7% CAGR growth pattern specific to North America through 2030, with projections reaching $1,454.3M, allowing for accurate revenue forecasting and investment planning in the region.
    • Competitive Landscape Intelligence : Identify market opportunities within North America's advanced pharmaceutical and nutraceutical sectors, understanding regional manufacturing capabilities and supply chain dynamics that differentiate this market from global competitors.
    • Regulatory & Quality Standards Insight : Access region-specific information on North America's stringent quality requirements and regulatory frameworks that influence capsule specifications, manufacturing standards, and market entry strategies for suppliers.
    • Strategic Market Positioning : Leverage North America-specific data to benchmark performance, identify growth segments within pharmaceuticals and supplements, and develop targeted go-to-market strategies for this high-value regional market.

    Frequently asked questions

    What is the current size of the North America empty capsules market?

    The North America empty capsules market is valued at $1,101.4 million in 2025 and is expected to grow to $1,454.3 million by 2030.

    What is the projected growth rate for empty capsules in North America?

    North America's empty capsules market is projected to grow at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2030.

    What factors drive demand for empty capsules in North America?

    North America's demand for empty capsules is driven by pharmaceutical manufacturing, dietary supplement production, contract manufacturing expansion, and consumer preference for capsule-based products.

    How does North America's regulatory environment impact the empty capsules market?

    North America's FDA oversight and stringent quality standards ensure high-quality capsule production and encourage investment in manufacturing facilities throughout the region.

    What types of capsules are most popular in North America?

    North America shows growing demand for both gelatin and plant-based capsules, with increasing consumer preference for vegetarian and vegan alternatives in the pharmaceutical and nutraceutical sectors.

    RESEARCH METHODOLOGY

    This research extensively utilized secondary sources, directories, and databases to gather valuable information for analyzing the global empty capsules market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to determine the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the Empty capsules market. The secondary sources used for this study includes European Federation of Pharmaceutical Industries and Associations (EFPIA), United States Food and Drug Administration (US FDA), Central Drugs Standard Control Organisation (CDSCO), Drugs Technical Advisory Board (DTAB), Pharmaceutical Research and Manufacturers of America (PhRMA), Indian Pharmaceutical Association (IPA), National Institutes of Health (NIH), World Health Organization (WHO), among others. Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After an initial assessment of the global empty capsules market landscape through secondary research, comprehensive primary research was conducted. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from the pharmaceutical, nutraceutical, and cosmetic industries, as well as research laboratories. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from leading empty capsules manufacturers, distributors, and channel partners. The research covered six major regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. About 70% of the primary interviews were with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and phone discussions to thoroughly understand market dynamics.

    The following is a breakdown of the primary respondents:

    Empty Capsules Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the empty capsules market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    A list of the major global players operating in the empty capsules market was generated.

    The revenues generated from their empty capsules product have been determined through annual reports and secondary sources (including paid databases)

    The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.

    The combined revenue share of the players was estimated and then added up to 100% to derive the global empty capsules market.

    All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Empty Capsules Market Size: Bottom-up and Top-down Approach

    Empty Capsules Market

    Data Triangulation

    After determining the market size through the estimation process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used whenever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A capsule is a form of solid oral dosage that consists of a container, usually made of gelatin or HPMC material, filled with a medicinal substance. Empty capsules are hard shells of various shapes, typically designed to hold a single dose of active ingredients. At the time of sale, these capsules are not filled with any pharmaceutical or nutraceutical ingredients. They are made in two halves: a smaller-diameter “body” that is filled and sealed with a larger-diameter “cap”.

    Stakeholders

    • Empty Capsules Manufacturing Companies
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Research Laboratories & Academic Institutes.
    • Market Research & Consulting Firms
    • Regulatory Bodies

    Report Objectives

    • To define, describe, and forecast the empty capsules market based on type, raw material, functionality, size, therapeutic application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the empty capsules market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global Empty capsules market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the empty capsules market
    • To benchmark players within the empty capsules market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business strategies and product footprints.

    Get the Full Empty Capsules Market Report

    Full forecast, segment splits, and company analysis for all Empty Capsules Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status